Chainalysis

Chainalysis is the category-defining blockchain forensics company at the moment its market structurally expands. The moat is a decade of accumulated attribution data — the entity clusterings linking addresses to real-world actors — that compounds with every investigation and cannot be replicated by writing better software; it is why US government agencies standardize on Reactor for the cases that matter and why regulated exchanges run KYT as compliance infrastructure they can never rip out. The demand curve just inflected: the GENIUS Act pulls stablecoins into federal oversight, banks with new OCC charters need transaction monitoring on day one, and every institution touching tokenized assets becomes a compliance customer — Chainalysis sells to crypto's regulation, not its price, making revenue counter-cyclical to the June 2026 downturn. Under co-founder Jonathan Levin (CEO since December 2024), the company hired its first CFO from Sword Health, acquired Hexagate (real-time threat detection, ~$60M) and Transpose (data platform), and is explicitly ramping M&A to consolidate the category while private-market winter prices targets cheaply. With $536M raised, an $8.6B Series F mark, and government contracts that renew through any market, Chainalysis is the compliance layer of an asset class governments have decided to regulate rather than ban.

The $8.6B Series F was priced in May 2022 at peak liquidity, and the market has since repriced the entire category: Elliptic — Chainalysis's longest-standing direct competitor, backed by Nasdaq and Deutsche Bank — raised its May 2026 Series D at roughly $670M, and the roster's own record notes Chainalysis secondary marks have reset well below peak. That comp implies the last-round anchor could be off by a large multiple, and Levin has told Fortune there is no near-term IPO — so there is no liquidity event to test the mark, only a slow grind of secondaries. The business has real structural ceilings: government-investigations revenue is lumpy, contract-driven, and exposed to budget politics; the exchange-compliance base consolidates as the industry does (every failed or acquired exchange is a lost logo); and TRM Labs and Elliptic compete price-down on the monitoring side while open-source tooling erodes the low end. The moat itself faces entropy — privacy pools, cross-chain fragmentation, and AI-generated laundering patterns raise attribution costs every year, and a single high-profile attribution error in a prosecution could damage the trust premium the whole franchise rests on. A four-year-old peak-cycle valuation, no IPO path, and a competitor priced at one-thirteenth the mark is a difficult setup to underwrite.